Cardiac Failure in Hemolytic Uremic Syndrome and Rescue with Extracorporeal Life Support
Overview
Pediatrics
Authors
Affiliations
Extrarenal involvement manifesting in the cardiovascular system is a rare but potentially fatal complication of hemolytic uremic syndrome (HUS). Current treatment is aimed at cardiovascular supportive measures while awaiting organ recovery. However, there are cases in which this recovery never occurs, and patients succumb secondary to heart failure. We report two cases of severe cardiac failure in children in the acute phase of HUS and the use of extracorporeal membrane oxygenation (ECMO) to support one patient to cardiac recovery. Clinicians should be aware of this potentially life-threatening cardiac involvement and should consider the use of ECMO for potentially salvageable children with HUS.
Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.
Sanders E, Brown C, Blaszak R, Crawford B, Prodhan P J Pediatr. 2021; 235:144-148.e4.
PMID: 33819463 PMC: 8316308. DOI: 10.1016/j.jpeds.2021.03.067.
Kelham M, Gleeson L, Alcalde I, Spiritoso R, Proudfoot A, Scully M J Intensive Care Soc. 2020; 21(2):191-193.
PMID: 32489417 PMC: 7238477. DOI: 10.1177/1751143719832184.
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.
Joseph A, Cointe A, Mariani Kurkdjian P, Rafat C, Hertig A Toxins (Basel). 2020; 12(2).
PMID: 31973203 PMC: 7076748. DOI: 10.3390/toxins12020067.
HUS-induced cardiac and circulatory failure is reversible using cardiopulmonary bypass as rescue.
Andersen R, Bjerre J, Povlsen J, Veien M, Kamperis K, Rittig S Pediatr Nephrol. 2017; 32(11):2155-2158.
PMID: 28780656 DOI: 10.1007/s00467-017-3736-y.
Rigamonti D, Simonetti G Eur J Pediatr. 2016; 175(12):1927-1931.
PMID: 27659663 DOI: 10.1007/s00431-016-2790-y.